Childhood Oligodendroglioma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-07-09
Clinical Trial Update: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors [Phase 1]
A Phase 1 trial evaluating veliparib (ABT-888) in combination with temozolomide for pediatric patients with recurrent or refractory CNS tumo…